Sohag university hospital
Sohag, Egypt
Location status: Recruiting
Location contact
Magdy M Amin, professor
CONTACT
NCT Number: NCT06920303
Investigator will compare accuracy of transcranial colour coded duplex with CT angiography in detecting arterial obstructions in patients presenting or with history of cerebrovascular ischemic strokes
Interested in participating?
Request InfoAll sexes
Observational
Sohag, Egypt
Location status: Recruiting
Magdy M Amin, professor
CONTACT
Cerebrovascular stroke is one of the most common causes of death and disability in the World. It accounts for almost 5% of all disability-adjusted life-years and 10% of all deaths worldwide.
Atherosclerosis is one of the major causes of ischemic stroke, it can lead to cerebrovascular stroke through progressive stenosis, occlusion of the extra or intracranial vessels and or arterio-arterial embolization from an atheromatous plaque.
Intracranial stenosis presents with one or recurrent ischemic strokes and transient ischemic attacks.
High-grade stenosis contributes to both the occurrence and magnitude of ischemic injury.
Overall, 50% of patients have either lacunar, subcortical, or cortical infarction.
The remaining patients with intracranial stenosis have multiple lesions involving a combination of cortical, subcortical, and lacunar infarctions.
There are extensive data about carotid atherosclerosis from American, European and Asian population. However, data from Egyptian ethnics are extremely rare.
Ethnic-racial factors are related to the development of extra- and intracranial atherosclerosis.
Intracranial stenosis causes about 10% of strokes in white people, 20-29% of transient ischemic attacks or strokes in black people, and up to 40-50% of strokes in Asian people.
Extracranial atherosclerosis is common among Caucasian stroke patients. For example, in the United States and Western communities, extracranial carotid artery disease was estimated to be responsible for 20-30% of strokes, while less common in Asian and African populations.
Intracranial arterial stenosis is prevalent in the Egyptian stroke population, similar to most non-white populations.
Transcranial Doppler is routinely performed to assess the blood flow in patients with cerebral ischaemia and provides important real-time information about cerebral haemodynamics.
Transcranial doppler can aid in the diagnostic work-up by detecting, localising and grading the severity of intracranial arterial obstruction.
Transcranial Doppler is an established tool for the non-invasive assessment of cerebral blood flow. Since transcranial doppler results vary with the skills and experience of the sonographer, it requires validation against contrast angiography.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
transcranial colour coded duplex is good non invasive tool in detect velocity and obstructions of intracranial arteries
Time frame: one year after enrolling one hundred cases
investigator will detect if transcranial color coded duplex can be used for diagnosing arterial obstructions in acute ischemic stroke by measuring the peak systolic velocity of different intracranial arteries, investigator will compare with CT angiography imaging results to assess the accuracy of transcranial color coded duplex in diagnosis of acute ischemic stroke.
Contact information is provided by the study sponsor or research team.
Hassan H Accuracy of Transcranial Colour Coded duplex Compared With CT, resident
CONTACT
Hazem K Ebrahim, professor
CONTACT
Sohag University
Other
Accuracy of Transcranial Colour Coded Duplex Compared With CT Angiography in Diagnosing Arterial Obstructions in Acute Ischemic Strokes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07324837
Brain Diseases, Cardiovascular Diseases
Ryazan, Ryazan Oblast, Russia
View Trial DetailsNCT06352619
Brain Diseases, Cardiovascular Diseases
Sydney, New South Wales, Australia
View Trial DetailsNCT07687706
Brain Diseases, Brain Ischemia
Busan, South Korea
View Trial DetailsNCT06094478
Brain Diseases, Cardiovascular Diseases
New Haven, Connecticut, United States
View Trial Details